Hyoscine Butyl Bromide Injection (Q2)

Hyoscine Butyl Bromide Injection (Q2)

Hydrocortisone Injection (Q2) (Q2)

Dexamethasone Injection (Q2)

Adrenaline Injection (V2) (Q2) Injection (Q2)

Dobutamine Injection (Q2) Injection (Q2)

Anti - D Immunoglobulin Injection (Q2) use in Nebulizer (Q2)

Ipratropium Bromide + Levosalbutamol Respules (V2) (Q2) Erythropoietin Injection (Q2)

Ondansetron Injection (Q2) MSE Relaxation for Years Of Experience and Turnover Yes | Complete Startup Relaxation for Years Of Experience and Turnover Yes | Complete Minimum number of bids required to disable automatic bid extension 1

-- Number of days for which Bid would be auto -- extended 7 Number of Auto Extension count 1 Bid to RA enabled Yes RA Qualification Rule H1-Highest Priced Bid Elimination Type of Bid Two Packet Bid Primary product category Hyoscine Butyl Bromide Injection Time allowed for Technical Clarifications during technical evaluation 2 Days Bid Document 1/80 ( )/Inspection Required (By Empanelled Inspection Authority Agencies pre-registered with GeM) No Evaluation Method Total value wise evaluation Arbitration Clause No Mediation Clause No Bid Details EMD Detail Advisory Bank State Bank of India EMD Amount 42245 ePBG Detail Advisory Bank State Bank of India (%) ePBG Percentage(%) 5.00 ( ) Duration of ePBG required (Months). 14 (a). EMD EXEMPTION: The bidder seeking EMD exemption

must submit the valid supporting document for the relevant category as per GeM GTC with the bid. Under MSE category

only manufacturers for goods and Service Providers for Services are eligible for exemption from EMD. Traders are excluded from the purview of this Policy. (b).

EMD & Performance securityshould be in favour of Beneficiary

wherever it is applicable. Beneficiary : Assistant Controller ( F &A) GMSH 16

Health Department Chandigarh

ABPMJAY GMSH16 CHANDIGARH

(Assistant Controller)